Pacific Biosciences of California, Inc. (PACB)
1.40
-0.15
(-9.68%)
USD |
NASDAQ |
Aug 28, 16:00
1.41
+0.01
(+0.71%)
After-Hours: 20:00
Pacific Biosciences of California PE Ratio
PE Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical PE Ratio Data
| Date | Value |
|---|---|
| March 30, 2021 | 356.97 |
| March 29, 2021 | 341.24 |
| March 26, 2021 | 366.27 |
| March 25, 2021 | 364.00 |
| March 24, 2021 | 353.16 |
| March 23, 2021 | 389.27 |
| March 22, 2021 | 414.66 |
| March 19, 2021 | 398.45 |
| March 18, 2021 | 379.86 |
| March 17, 2021 | 415.14 |
| March 16, 2021 | 398.57 |
| March 15, 2021 | 420.38 |
| March 12, 2021 | 403.93 |
| March 11, 2021 | 423.12 |
| March 10, 2021 | 382.36 |
| March 09, 2021 | 374.02 |
| March 08, 2021 | 326.22 |
| March 05, 2021 | 348.87 |
| March 04, 2021 | 343.03 |
| March 03, 2021 | 369.07 |
| March 02, 2021 | 409.30 |
| March 01, 2021 | 419.79 |
| February 26, 2021 | 364.36 |
| February 25, 2021 | 371.57 |
| February 24, 2021 | 426.10 |
| Date | Value |
|---|---|
| February 23, 2021 | 442.43 |
| February 22, 2021 | 446.25 |
| February 19, 2021 | 512.87 |
| February 18, 2021 | 509.42 |
| February 17, 2021 | 526.46 |
| February 16, 2021 | 552.68 |
| February 12, 2021 | 599.76 |
| February 11, 2021 | 609.65 |
| February 10, 2021 | 547.08 |
| February 09, 2021 | 471.28 |
| February 08, 2021 | 460.67 |
| February 05, 2021 | 431.70 |
| February 04, 2021 | 417.28 |
| February 03, 2021 | 415.02 |
| February 02, 2021 | 420.08 |
| February 01, 2021 | 407.39 |
| January 29, 2021 | 385.58 |
| January 28, 2021 | 408.58 |
| January 27, 2021 | 370.20 |
| January 26, 2021 | 391.90 |
| January 25, 2021 | 428.49 |
| January 22, 2021 | 446.01 |
| January 21, 2021 | 432.78 |
| January 20, 2021 | 459.89 |
| January 19, 2021 | 479.14 |
Price to Earnings Ratio (PE Ratio) Definition
The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS Diluted (TTM). This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. Because of this, PE Ratio is great to evaluate from a relative standpoint with other similar companies.
PE Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
PE Ratio Benchmarks
| Illumina, Inc. | 40.18 |
| Danaher Corp. | 38.36 |
| Agilent Technologies, Inc. | 30.29 |
| Bio-Rad Laboratories, Inc. | 46.97 |
| Thermo Fisher Scientific, Inc. | 33.47 |
PE Ratio Related Metrics
| PS Ratio | 2.679 |
| Price | 1.40 |
| Earnings Yield | -30.79% |
| Market Cap | 435.13M |